Logo Logo Logo Logo Logo
  • Home
  • Who We Are
    • Capabilities Statement
    • Our Mission & Vision
    • Our Core Values
    • About UNISHKA
    • Our Team
    • In The Media
    • Diversity & Commitments
  • What We Do
    • Systems Integrity Development™
    • Reports of Significant Corruption
    • Political and Electoral Integrity Program
    • Practice Areas
    • Our Publications
  • Where We Work
  • News
  • Careers
  • Contact
  • Search
  • Home
  • Who We Are
    • Capabilities Statement
    • Our Mission & Vision
    • Our Core Values
    • About UNISHKA
    • Our Team
    • In The Media
    • Diversity & Commitments
  • What We Do
    • Systems Integrity Development™
    • Reports of Significant Corruption
    • Political and Electoral Integrity Program
    • Practice Areas
    • Our Publications
  • Where We Work
  • News
  • Careers
  • Contact
  • Search
 

US Court Annuls Purdue Pharma Opioid Settlement Plan

Corruption News

US Court Annuls Purdue Pharma Opioid Settlement Plan

December 21, 2021
by Cole

SARAJEVO, 21 DECEMBER (OCCRP)

A U.S. District Court judge last week dismissed the bankruptcy plan of Purdue Pharma that would grant its owners immunity from thousands of lawsuits related to the company’s role in the opioid epidemic.

Purdue Pharma has been accused of pushing doctors to prescribe its OxyContin, this way fueling the opioid crisis that has killed nearly half a million people in the U.S. over the past 20 years.

With its creditors, the company developed in September a plan through a bankruptcy court that would turn Purdue into a company that still sells opioids but the profits would go toward fighting the crisis. Moreover, the plan required that Purdue Pharma develop new anti-addiction and anti-overdose drugs and give them for free or sell at little cost.

Part of the plan was that the Sackler family, which owns the company, would give up ownership, which would also grant them immunity from lawsuits of the victims.

But U.S. District Judge Colleen McMahon in New York overturned the bankruptcy court ruling and argued that the Sacklers were “well aware that they were exposed to personal liability over OxyContin,” and over the years withdrew billions from Purdue between 2008 and 2017, putting more than half of it in offshore companies or trusts that could not be reached in bankruptcy.

Attorney General Merrick B. Garland welcomed the Court’s decision and said that “the bankruptcy court did not have the authority to deprive victims of the opioid crisis of their right to sue the Sackler family.”

Following the decision, the chairman of the Purdue board of directors, Steve Miller, said the ruling would “delay, and perhaps end, the ability of creditors, communities, and individuals to receive billions in value to abate the opioid crisis.”

The company stated that it would appeal the ruling.

See the Orginal Article
Share:
Share on:
1
Previous post Next post
Corporate Links

Code of Conduct
Gender Policy
Affirmative Action Policy
Ethics Policy / Conflict of Interest Policy
Terms & Conditions
Capabilities Statement

Contact Us

416 4th Street
Juneau, AK 99801
907.419.1230
Contact Information
Staff Links

Quick Links

Terms of Use
Privacy Policy
Site Map
Don’t Sell My Info
Staff Portal
Report Compliance Violations

© 2022 UNISHKA Research Service, Inc.

All Rights Reserved

This website uses cookies to improve your website experience and provide more personalized services to you. To find out more about the cookies we use, see our Privacy Policy. By clicking “Accept”, you consent to the use of ALL the cookies.
PRIVACY POLICYACCEPT
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT